Che Ma

X-ray structure of EmrE supports dual topology model.

EmrE, a multidrug transporter from Escherichia coli, functions as a homodimer of a small four-transmembrane protein. The membrane insertion topology of the two monomers is controversial. Although the EmrE protein was reported to have a unique orientation in the membrane, models based on electron microscopy and now defunct x-ray structures, as well as recent biochemical studies, posit an antiparallel dimer. We have now reanalyzed our x-ray data on EmrE. The corrected structures in complex with a transport substrate are highly similar to the electron microscopy structure. The first three transmembrane helices from each monomer surround the substrate binding chamber, whereas the fourth helices participate only in dimer formation. Selenomethionine markers clearly indicate an antiparallel orientation for the monomers, supporting a “dual topology” model.

Glycans on influenza hemagglutinin affect receptor binding and immune response

Recent cases of avian influenza H5N1 and the swine-origin 2009 H1N1 have caused a great concern that a global disaster like the 1918 influenza pandemic may occur again. Viral transmission begins with a critical interaction between hemagglutinin (HA) glycoprotein, which is on the viral coat of influenza, and sialic acid (SA) containing glycans, which are on the host cell surface. To elucidate the role of HA glycosylation in this important interaction, various defined HA glycoforms were prepared, and their binding affinity and specificity were studied by using a synthetic SA microarray. Truncation of the N-glycan structures on HA increased SA binding affinities while decreasing specificity toward disparate SA ligands. The contribution of each monosaccharide and sulfate group within SA ligand structures to HA binding energy was quantitatively dissected. It was found that the sulfate group adds nearly 100-fold (2.04 kcal/mol) in binding energy to fully glycosylated HA, and so does the biantennary glycan to the monoglycosylated HA glycoform. Antibodies raised against HA protein bearing only a single N-linked GlcNAc at each glycosylation site showed better binding affinity and neutralization activity against influenza subtypes than the fully glycosylated HAs elicited. Thus, removal of structurally nonessential glycans on viral surface glycoproteins may be a very effective and general approach for vaccine design against influenza and other human viruses.

Expression, purification, and activities of full‐length and truncated versions of the integral membrane protein Vpu from HIV‐1

Vpu is an 81‐residue accessory protein of HIV‐1. Because it is a membrane protein, it presents substantial technical challenges for the characterization of its structure and function, which are of considerable interest because the protein enhances the release of new virus particles from cells infected with HIV‐1 and induces the intracellular degradation of the CD4 receptor protein. The Vpu‐mediated enhancement of the virus release rate from HIV‐1‐infected cells is correlated with the expression of an ion channel activity associated with the transmembrane hydrophobic helical domain. Vpu‐induced CD4 degradation and, to a lesser extent, enhancement of particle release are both dependent on the phosphorylation of two highly conserved serine residues in the cytoplasmic domain of Vpu. To define the minimal folding units of Vpu and to identify their activities, we prepared three truncated forms of Vpu and compared their structural and functional properties to those of full‐length Vpu (residues 2–81). Vpu2–37 encompasses the N‐terminal transmembrane α‐helix; Vpu2–51 spans the N‐terminal transmembrane helix and the first cytoplasmic α‐helix; Vpu28–81 includes the entire cytoplasmic domain containing the two C‐terminal amphipathic α‐helices without the transmembrane helix. Uniformly isotopically labeled samples of the polypeptides derived from Vpu were prepared by expression of fusion proteins in E. coli and were studied in the model membrane environments of lipid micelles by solution NMR spectroscopy and oriented lipid bilayers by solid‐state NMR spectroscopy. The assignment of backbone resonances enabled the secondary structure of the constructs corresponding to the transmembrane and the cytoplasmic domains of Vpu to be defined in micelle samples by solution NMR spectroscopy. Solid‐state NMR spectra of the polypeptides in oriented lipid bilayers demonstrated that the topology of the domains is retained in the truncated polypeptides. The biological activities of the constructs of Vpu were evaluated. The ion channel activity is confined to the transmembrane α‐helix. The C‐terminal α‐helices modulate or promote the oligomerization of Vpu in the membrane and stabilize the conductive state of the channel, in addition to their involvement in CD4 degradation.

Crystal structure of the membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli.

Drug-resistant bacteria have caused serious medical problems in recent years, and the need for new antibacterial agents is undisputed. Transglycosylase, a multidomain membrane protein essential for cell wall synthesis, is an excellent target for the development of new antibiotics. Here, we determined the X-ray crystal structure of the bifunctional transglycosylase penicillin-binding protein 1b (PBP1b) from Escherichia coli in complex with its inhibitor moenomycin to 2.16-Å resolution. In addition to the transglycosylase and transpeptidase domains, our structure provides a complete visualization of this important antibacterial target, and reveals a domain for protein–protein interaction and a transmembrane helix domain essential for substrate binding, enzymatic activity, and membrane orientation.

Nuclear magnetic resonance of membrane-associated peptides and proteins.

Structural biology is based on the premise that the fundamental understanding of biological functions lies in the three-dimensional structures of proteins and other biopolymers. The two well-established experimental methods for determining the structures of proteins work very well for globular proteins: witness the explosive growth of the Protein Data Bank (PDB). However, approximately 30% of all expressed polypeptides are membrane-associated, and neither X-ray crystallography nor solution nuclear magnetic resonance (NMR) spectroscopy is very effective for these proteins. The lipids required for the structural integrity and functionality of membrane proteins impede crystallization as well as the rate of overall reorientation in solution. NMR of Proteins NMR spectroscopy can be applied to wide variety of samples, ranging from isotropic solutions to crystalline powders, including those with slowly reorienting or immobile macromolecules, such as membrane proteins in lipid environments. NMR is capable of resolving signals from all atomic sites in proteins, and each site has several well-characterized nuclear spin interactions that can be used as sources of information about molecular structure and dynamics, as well as chemical interactions. The spin interactions can be probed through radio frequency (rf) irradiations and sample manipulations that lead to complementary strategies for NMR spectroscopy of membrane proteins reconstituted in lipid micelles or bilayers. Comparisons between the results obtained with solution NMR experiments on lipid micelle samples, and solid-state NMR experiments on lipid bilayer samples, are especially valuable for membrane proteins with predominantly helical secondary structure. Multidimensional solution NMR methods can be successfully applied to relatively small membrane proteins in micelles; however, the size limitation is substantially more severe than for globular proteins because the many lipid molecules associated with each polypeptide slow its overall reorientation rate. In particular, using currently available instruments and methods, it is difficult to resolve, assign, and measure the “long-range” nuclear overhauser effects (NOEs) between hydrogens on hydrophobic side-chains that are needed to determine tertiary structures based on distance constraints. However, the ability to weakly align membrane proteins in micelles enables the measurement of residual dipolar couplings, and improves the feasibility of determining the structures of membrane proteins using solution NMR methods. Nonetheless, it is highly desirable to determine the structures of membrane proteins in the definitive environment of phospholipid bilayers, where solution NMR methods fail completely for all classes of membrane proteins. Fortunately, solid-state NMR spectroscopy is well suited for peptides and proteins immobilized in phospholipid bilayers. Both oriented sample and magic angle spinning methods provide approaches to measuring orientational and distance parameters for structure determination.

A common glycan structure on immunoglobulin G for enhancement of effector functions

Significance Antibodies are important therapeutic agents and have been used for the treatment of many diseases, including infectious and inflammatory diseases, and cancer. The therapeutic efficacy of an antibody is usually determined not only by the selectivity and affinity toward the target but also by the Fc-glycan structure interacting with the Fc receptors on immune cells. This study describes the preparation of various antibodies with different Fc-glycan structures as homogeneous glycoforms for the investigation of their effector activities. During this study, it was discovered that the biantennary N-glycan structure with two terminal alpha-2,6-linked sialic acids is a common and optimal structure that is able to enhance the activities of antibodies against cancer, influenza, and inflammatory diseases. Antibodies have been developed as therapeutic agents for the treatment of cancer, infection, and inflammation. In addition to binding activity toward the target, antibodies also exhibit effector-mediated activities through the interaction of the Fc glycan and the Fc receptors on immune cells. To identify the optimal glycan structures for individual antibodies with desired activity, we have developed an effective method to modify the Fc-glycan structures to a homogeneous glycoform. In this study, it was found that the biantennary N-glycan structure with two terminal alpha-2,6-linked sialic acids is a common and optimized structure for the enhancement of antibody-dependent cell-mediated cytotoxicity, complement-dependent cytotoxicity, and antiinflammatory activities.

Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections

Significance Influenza epidemics continue to be a threat to public health, and the recent human cases of avian viruses of H5N1, H7N9, and H6N1 in Asia raise the possibility of a new disastrous influenza pandemic. Although an effective universal vaccine that can protect from influenza viruses from different subtypes or even both type A and B is still far from reality, our unique findings, showing that monosaccharide glycosylated HA vaccine induces broader protection against different strains, may lead to a better influenza vaccine design that does not require frequent updates and annual immunizations. This strategy may also map out a new direction for development of universal flu vaccines and be applied to vaccine design for other human viruses. The 2009 H1N1 pandemic and recent human cases of H5N1, H7N9, and H6N1 in Asia highlight the need for a universal influenza vaccine that can provide cross-strain or even cross-subtype protection. Here, we show that recombinant monoglycosylated hemagglutinin (HAmg) with an intact protein structure from either seasonal or pandemic H1N1 can be used as a vaccine for cross-strain protection against various H1N1 viruses in circulation from 1933 to 2009 in mice and ferrets. In the HAmg vaccine, highly conserved sequences that were originally covered by glycans in the fully glycosylated HA (HAfg) are exposed and thus, are better engulfed by dendritic cells (DCs), stimulated better DC maturation, and induced more CD8+ memory T cells and IgG-secreting plasma cells. Single B-cell RT-PCR followed by sequence analysis revealed that the HAmg vaccine activated more diverse B-cell repertoires than the HAfg vaccine and produced antibodies with cross-strain binding ability. In summary, the HAmg vaccine elicits cross-strain immune responses that may mitigate the current need for yearly reformulation of strain-specific inactivated vaccines. This strategy may also map a new direction for universal vaccine design.

Domain requirement of moenomycin binding to bifunctional transglycosylases and development of high-throughput discovery of antibiotics

Moenomycin inhibits bacterial growth by blocking the transglycosylase activity of class A penicillin-binding proteins (PBPs), which are key enzymes in bacterial cell wall synthesis. We compared the binding affinities of moenomycin A with various truncated PBPs by using surface plasmon resonance analysis and found that the transmembrane domain is important for moenomycin binding. Full-length class A PBPs from 16 bacterial species were produced, and their binding activities showed a correlation with the antimicrobial activity of moenomycin against Enterococcus faecalis and Staphylococcus aureus. On the basis of these findings, a fluorescence anisotropy-based high-throughput assay was developed and used successfully for identification of transglycosylase inhibitors.

Deuterium/Hydrogen Exchange Factors Measured by Solution Nuclear Magnetic Resonance Spectroscopy as Indicators of the Structure and Topology of Membrane Proteins

Deuterium/hydrogen exchange factors (chi) were measured for the backbone amide sites of the membrane-bound forms of the 50-residue fd coat protein and the 23-residue magainin2 peptide in lipid micelles by solution nuclear magnetic resonance spectroscopy. By combining kinetic and thermodynamic effects, deuterium/hydrogen exchange factors overcome the principal limitations encountered in the measurements of kinetic protection factors and thermodynamic fractionation factors for membrane proteins. The magnitudes of the exchange factors can be correlated with the structure and topology of membrane-associated polypeptides. In fd coat protein, residues in the transmembrane helix have exchange factors that are substantially smaller than those in the amphipathic surface helix or the loop connecting the two helices. For the amphipathic helical peptide, magainin2, the exchange factors of residues exposed to the solvent are appreciably larger than those that face the hydrocarbon portion of membrane bilayers. These examples demonstrate that deuterium/hydrogen exchange factors can be measured by solution NMR spectroscopy and used to identify residues in transmembrane helices as well as to determine the polarity of amphipathic helices in membrane proteins.

Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-κB-mediated antiapoptotic pathway.

Gain of function of membrane receptor was a good strategy exploited by cancer cells to benefit own growth and survival. Overexpression of HER2 has been found to serve as a target for developing trastuzumab to treat 20–25% of breast cancer. However, little or none of the other membrane receptor was found to be useful as a potential target for breast cancer treatment since then. Here, we showed that amplified signaling of interleukin-17 receptor B (IL-17RB) and its ligand IL-17B promoted tumorigenicity in breast cancer cells and impeded acinus formation in immortalized normal mammary epithelial cells. External signal transmitted through IL-17RB activated nuclear factor-κB to upregulate antiapoptotic factor Bcl-2 and induced etoposide resistance. Elevated expression of IL-17RB had a stronger correlation with poor prognosis than HER2 in breast cancer patients. Interestingly, breast cancer patients with high expression of IL-17RB and HER2 had the shortest survival rate. Depletion of IL-17RB in trastuzumab-resistant breast cancer cells significantly reduced their tumorigenic activity, suggesting that IL-17RB and HER2 have an independent role in breast carcinogenesis. Furthermore, treatment with antibodies specifically against IL-17RB or IL-17B effectively attenuated tumorigenicity of breast cancer cells. These results suggest that the amplified IL-17RB/IL-17B signaling pathways may serve as a therapeutic target for developing treatment to manage IL-17RB-associated breast cancer.